EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Association of CSF visinin-like protein 1 levels with cerebral glucose metabolism among older adults

Zhaowei Wang, Sufeng Xiao, Meiping Wan iD, Alzheimer’s Disease Neuroimaging Initiative

PLOS One · 2025

DOI: 10.1371/journal.pone.0329386 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Zhaowei Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Qianjiang Central Hospital of Hubei Province, Hubei, China. Hauptthemen laut MEDLINE: Glucose, Neurocalcin, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

CSF visinin-like protein 1 (VILIP-1) levels have exhibited potential utility as a marker of neuronal damage and are increased in Alzheimer’s disease (AD). The levels of CSF VILIP-1 have been associated with memory decline and hippocampal atrophy, while no studies have investigated the association between CSF VILIP-1 levels and cerebral glucose metabolism among older adults.

Methods

Study participants had available baseline CSF VILIP-1 data and more than two assessments of 18-fluorodeoxyglucose positron emission tomography ([ 18 F] FDG-PET) brain imaging. Linear mixed-effects models were used to examine the association between baseline CSF VILIP-1 levels and longitudinal changes in FDG-PET over time. Models were performed separately for the cognitively unimpaired (CU) and cognitively impaired (CI) participants.

Results

Among CU older adults, higher CSF VILIP-1 levels were marginally associated with a faster reduction in cerebral glucose metabolism. In CI older adults, CSF VILIP-1 levels were significantly associated with a faster reduction in cerebral glucose metabolism.

Conclusion

These results provide novel insights into the relationship between neuronal injury and cerebral glucose metabolism, highlighting the potential of CSF VILIP-1 as a biomarker for monitoring and predicting the progression of neurodegenerative processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucoseNeurocalcinBrainHumansAgedMaleFemalePositron-Emission TomographyFluorodeoxyglucose F18Aged, 80 and overBiomarkersAlzheimer DiseaseCognitive DysfunctionMiddle Aged

Substanzen

GlucoseNeurocalcinVSNL1 protein, humanFluorodeoxyglucose F18Biomarkers

Autor:innen und Institutionen

  • Department of Neurology, Qianjiang Central Hospital of Hubei Province, Hubei, China.
  • Department of Rehabilitation, Qianjiang Central Hospital of Hubei Province, Hubei, China.

ORCID-Profile: Meiping Wan

Zitieren

APA

Wang, Z., Xiao, S., Wan, M., & Alzheimer’s Disease Neuroimaging Initiative (2025). Association of CSF visinin-like protein 1 levels with cerebral glucose metabolism among older adults. PLOS One. https://doi.org/10.1371/journal.pone.0329386

Vancouver

Wang Z, Xiao S, Wan M, Alzheimer’s Disease Neuroimaging Initiative. Association of CSF visinin-like protein 1 levels with cerebral glucose metabolism among older adults. PLOS One. 2025. doi:10.1371/journal.pone.0329386

BibTeX
@article{Wang2025,
  author = {Wang, Zhaowei and Xiao, Sufeng and Wan, Meiping and Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Neuroimaging Initiative},
  title = {Association of CSF visinin-like protein 1 levels with cerebral glucose metabolism among older adults},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0329386}
}
Kostenlos starten →